HomeGreater Than Icon
Coral Laboratories LtdGreater Than Icon
Coral Laboratories Ltd Financials
Company Logo

Coral Laboratories Ltd Financial Statement

Coral Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue33.22
Operating Expense20.92
Net Profit8.80
Net Profit Margin26.49
Earning Per Share24.64
EBIDTA12.27
Effective Tax Rate23.98

Coral Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual83.66
Operating Expenses Annual67.42
Operating Profit Annual22.71
Interest Annual0.00
Depreciation1.97
Net Profit Annual15.79
Tax Annual4.94

Coral Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning6.13
Cash Flow from Operations-5.46
Cash Flow from Investing1.40
Cash Flow from Financing0.01
Cash Flow at the End2.07

Coral Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)27.15
PBIT Margin (%)24.78
PBT Margin (%)24.78
Net PROFIT Margin (%)18.87
Return On Networth / Equity (%)9.50
Return On Networth /Employed (%)12.26
Return On Assets (%)9.25
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)0.49

Coral Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual23.34
Total Current Assets Annual153.85
Non Current Assets Annual51.83
Total Shareholders Funds Annual177.50
Total Assets Annual205.68

Coral Laboratories Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 5, 2024, Coral Laboratories Ltd has a market capitalization of 132.59 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Coral Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.00.
In FY 2023 , Coral Laboratories Ltd recorded a total revenue of approximately 83.66 Cr marking a significant milestone in the company's financial performance.
Coral Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.2% and 0.1% annually, respectively..
Coral Laboratories Ltd's current PE ratio is 8.40.
Coral Laboratories Ltd's ROCE averaged 8.2% from the FY ending March 2022 to 2024, with a median of 7.4%. It peaked at 11.7% in March 2024, reflecting strong capital efficiency over the period..
Coral Laboratories Ltd's latest EBIT is Rs. 20.73 Cr, surpassing the average EBIT of Rs. 13.77 Cr over the 5 years..